Australian Clinical Labs hits all-time low on weak FY results

Australian Clinical Labs

22/08/2023 06:02

** Shares of Australian Clinical Labs Ltd  ACL.AX  fall as
much as 14.1% to record low of A$2.765 
    ** Pathology services provider posts statutory profit
attributable of A$35.9 mln ($23.04 mln) for full-year, down
79.9%
    ** Co posts statutory total revenue from ordinary activities
of A$697.1 mln for the year, down 30.0% 
    ** Co sees biggest intraday fall of all time 
    ** About 2.2 mln shares change hand compared to 30-day
average trading volume of 431,664 shares 
    ** Stock up 8.1% YTD as of last close 
   


($1 = 1.5581 Australian dollars)

 (Reporting by John Biju in Bengaluru)
 ((John.Biju@thomsonreuters.com;))